Notification of Major Interest in Shares

RNS Number : 0225M

Faron Pharmaceuticals Oy

07 October 2016

 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii			Faron Pharmaceuticals Oy
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):	Disclosure as per Company´s Articles of Association			Yes
3. Full name of person(s) subject to the notification obligation: iii		City Financial Investment Company Limited, acting as Investment Manager and Authorised Corporate Director of the City Financial Absolute Equity Fund
4. Full name of shareholder(s)  (if different from 3.):iv		BNY Mellon Trust and Depositary as Trustee to the City Financial Absolute Equity Fund
5. Date of the transaction and date on which the threshold is crossed or reached: v		21.9.2016
6. Date on which issuer notified:		4.10.2016
7. Threshold(s) that is/are crossed or reached: vi, vii		Above 3%, 3.80%

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type of shares if possible using the ISIN CODE

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of Shares

Number of Voting Rights

Number of shares

Number of voting rights

% of  voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

zero

zero

1,000,000

1,000,000

zero

3.80%

zero

Ordinary Shares FI40000153309

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date xiii

Exercise/ Conversion Period xiv

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financial instrument

Exercise price

Expiration date xvii

Exercise/ Conversion period xviii

Number of voting rights instrument refers to

% of voting rights xix, xx

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

1,000,000

3.80%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi
The voting rights are managed and controlled by City Financial Investment Company Limited, Investment manager and ACD to the City Financial Absolute Equity Fund.
Proxy Voting:
10. Name of the proxy holder:
11. Number of voting rights proxy holder will cease to hold:
12. Date on which proxy holder will cease to hold voting rights:
13. Additional information:	Notification using the total voting rights figure of 26,311,704
14. Contact name:	Chris Sturdee
15. Contact telephone number:	[phone]

 

END

 

 

HOLBDBDGGSGBGLR